1Glassman AH. Clinical management of cardiovascular risk during treatment with psychotropic drugs [ J ]. J Clin Psychiatry, 2002,63 (Suppl9) :12 - 17.
2Stimmel GL, Gutierrez MA, Lee V. Ziprasidone : an atypical antipsy- chotic drug for the treatment of schizophrenia[ J]. Clinical Therapeu- tics,2002,24 ( 1 ) :21 - 27.
3Con'ell CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents [ J ]. Am Acad Child Adolesc Psychiatry ,2006,45 (7) :771 - 791.
4Gupta S, Nienhaus K, Shah SA. Quetiapine and QTc issues:a case re- port[J]. J Clin Psychiatry,2003,64(5) :612 -613.